- 19 2019/06
iSCLife® products bring new treatments to pat...
The clinical application known as "Clinical study of human umbilical cord mesenchymal stem cells (19#iSCLife®-CSD) for the treatment of uterine traumatic healing failure" with stem cell product has been approved by the state and fully supported by Professor Zhang Weishe, director of the Department of Obstetrics and Gynecology, Xiangya Hospital.
查看详细
-
11 2019/02Salute, the SCLnow® heroes on duty during ...
When we were home for the New YearThere was such a group of people Standing fast on dutyWe thank them for their selfless dedicationGreat respects to the SCLnow® heroes
查看详细 -
02 2019/02A tribute to the heroes in the front line, SCLn...
The bustling city is getting desertedGlorious night slowly quietTouch the soul with responsibilityHold fast to the post, never give up
查看详细 -
31 2019/01New addition to the SCLnow® Stem Cell Clinical ...
So far, three human umbilical cord mesenchymal stem cell clinical research projects jointly submitted by SCLnow® and XiangYa Hospital of Central South University in 2018 and 2019 have been reviewed and successfully filed by the Expert Committees of two national ministries and commission for registration in the National Medical Research Registration Information
查看详细 -
22 2019/01What is Peppa pig ? What is iSCL stem cell?
It is Peppa pig that warms your heartIt is iSCL stem cell that tells you about the legend of immortality
查看详细 -
17 2019/01SCLnow® continues to write legends in 2019
SCLnow®mesenchymal stem cells (iSCL stem cell®), as a quality control enterprise for biological resources, have begun to initiate standardization process within SCLnow®global entities, and the composition, structure and contents of the corporate standards are consistent with ISO/TC 276.
查看详细